Our medicines treat major diseases, from cancer and heart disease to rare genetic disorders, and are distributed in approximately 140 countries around the world.
We focus on five core therapeutic areas where there are high unmet patient needs:
In addition, we have research and in-market programs in Ophthalmology and Respiratory.
Through Sandoz, we also offer around 1 000 generics and biosimilars in areas ranging from cardiovascular and respiratory illnesses to conditions affecting the central nervous system.
Top 10 innovative medicines by sales
Brand / 2022 net sales (USD, millions)
Cosentyx An injectable treatment for several systemic inflammatory conditions
Entresto An oral medicine for heart failure and hypertension
Promacta/Revolade An oral treatment for certain blood disorders
Gilenya An oral treatment for relapsing forms of multiple sclerosis
Tasigna An oral treatment for a type of chronic myeloid leukemia
Lucentis An injectable medicine for certain conditions of the retina
Tafinlar + Mekinist An oral combination therapy for certain types of skin, thyroid and lung cancers
Jakavi An oral therapy for certain rare blood disorders
Zolgensma A one-time intravenous gene therapy for spinal muscular atrophy in babies and young children
Xolair An injectable therapy for certain respiratory and immunological conditions, including severe allergic asthma